Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer

BACKGROUND: Clinically, few patients with locally advanced cervical cancer (LACC) are insensitive to neoadjuvant chemotherapy (NACT). Recent studies have reported that circulating microRNAs (miRNAs) may be involved in the response to NACT. The aim of this study was to discover the potential miRNAs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Kangni, Yang, E., Cui, Tao, Li, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682073/
https://www.ncbi.nlm.nih.gov/pubmed/36439477
http://dx.doi.org/10.3389/fonc.2022.1036710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682073/
https://www.ncbi.nlm.nih.gov/pubmed/36439477
http://dx.doi.org/10.3389/fonc.2022.1036710

Ejemplares similares